Vitania: The Real Liquidity Test Is Debt Rollovers, Not FFO

FFO Is Not The Liquidity Picture

The main article already established that Vitania's income-producing base did not break, but that the market would read 2026 through two lenses: re-leasing and debt rollovers. This follow-up isolates the second one, because that is where the gap sits between a number that looks comfortable at first glance and the actual liquidity test.

On the surface, the company does not look like a name that has already lost control. At year-end it still showed an A2 stable rating, net debt to net CAP of 61.6% and an equity-to-assets ratio of 33%. Those are balance-sheet figures for a company that still has capital. But that is exactly why the liquidity question needs to be read carefully: the issue is not whether equity exists, but whether there is enough room to carry long-duration assets, projects nearing completion and short-dated debt through the next two years without paying materially more for funding and without forcing the company to inject much more cash from its own pocket.

This is where two cash lenses have to be separated. The normalized earning-power lens is FFO, which stood at NIS 46.3 million nominal and NIS 62.9 million real. The all-in cash-flexibility lens asks how much cash is left after actual project investment, debt service, dividends and the rest of the period's cash uses. On that test, the picture looks very different.

That chart is the core of this continuation. Vitania ended 2025 with positive FFO, but actual liquidity was not funded out of FFO. Operating cash flow was NIS 44.9 million, and even that was described as being generated in part by office-inventory sales. Against it stood NIS 206.5 million of investing outflow. In other words, the company did not stay liquid because the rent roll alone created spare cash. It stayed liquid because banks and debt markets covered the gap.

This is not an argument against using FFO. For income-producing real estate, it is a legitimate metric. It is an argument against using FFO as a substitute for liquidity analysis. In Vitania's case, those are no longer the same thing.

The Working-Capital Deficit Is Really A Maturity Schedule

The group ended 2025 with a working-capital deficit of about NIS 725 million, including assets held for sale. The company's own explanation is direct: the deficit comes mainly from short-term bank credit, commercial paper, current maturities of bank loans and current maturities of bonds that were taken to finance long-duration investments.

That is exactly what FFO does not capture. The deficit does not stem from a collapse in current operations. It stems from funding long assets and part of the development pipeline with a large layer of short-dated debt or debt that has already moved into the short bucket. In 2025, short-term bank credit including current maturities rose to NIS 938.2 million from NIS 537.8 million a year earlier, while long-term bank loans fell to only NIS 140.9 million from NIS 499.3 million in 2024. Commercial paper stayed at about NIS 175.1 million, and current bond maturities stood at NIS 80.2 million.

The implication is not only a shorter tenor. It is also price. The average-interest table shows a 6.53% average rate on short-term bank sources versus 3.28% on long-term bank sources. The commercial paper carried a 4.6% rate at year-end. So as long as the company keeps a large layer of short funding, the rollover test is also a pricing test, not only an availability test.

The commercial paper is the clearest example. On one side, it is unsecured and has no financial covenants, so it looks convenient and flexible. On the other, it extends one year at a time, and each purchaser can shorten the term with 7 business days' notice. It reduces collateral pressure, but it does not remove the market-access test. Anyone reading the CP as patient capital could miss that it only looks long as long as investors agree to keep extending it.

The Two-Year Liquidity Forecast Looks Comfortable Only After Rollovers Are Built In

The board concluded that there is no reasonable concern that the company will fail to meet its obligations over the next two years. That conclusion matters, but what matters more is what supports it. It is not built on a large cash pile already sitting inside the company. It is built on a chain of assumptions: unused credit lines, the ability to add loans against properties that are not yet leveraged, the ability to raise debt in capital markets, cash upstreaming from wholly owned subsidiaries, dividends from jointly controlled entities, asset sales, and even the option to defer parts of the development program if needed.

The sharpest assumption is stated plainly: the company has loans maturing within the forecast horizon, and it assumes it will be able to refinance or extend all of them so that it will not need to repay them in cash when due. That is the heart of the story. The forecast surplus is not a pre-financing operating surplus. It is a surplus that appears only after rollovers are built into the model.

The 2026 figures make this especially clear. Out of NIS 484 million of expected sources, NIS 345 million comes from available bank lines and line increases. The company's own rent collections are expected to contribute NIS 91 million, subsidiaries another NIS 21 million, asset sales NIS 6 million, and opening cash NIS 21 million. So the single largest component in the expected funding picture for the coming year is not rent, not FFO and not existing cash. It is the banks.

2027 does not really fix that. Out of NIS 496 million of expected sources, NIS 119 million depends on line increases the company intends to negotiate during that year, NIS 71 million on asset sales, NIS 35 million on dividends from associates, and only NIS 110 million on rent collection from the company itself. That is why the forecast surplus of NIS 123 million for 2026 and NIS 220 million for 2027 should be read as the output of a successful financing plan, not as proof that operations alone create a wide liquidity cushion.

The uses side explains why. In 2026 the company expects NIS 91 million of net project-development investment, NIS 148 million of principal and interest payments to banks and others, and NIS 97 million of bond principal and interest payments. Even on the company's own forecast, 2026 is not a year in which projects simply stop consuming capital. It is a year in which Vitania still needs to complete, still needs to service debt and still needs to roll funding.

In The End, This Is Tested At The Solo Level And Inside The Projects

There is one more layer that is easy to miss: at the parent-company level, excluding held entities, cash and cash equivalents stood at only NIS 15.6 million at the end of 2025. The NIS 21 million opening balance in the two-year forecast is made of NIS 16 million at the solo company and NIS 5 million in wholly owned subsidiaries whose cash can be upstreamed without restriction.

Against that, the company-only liquidity-risk table shows NIS 1.32 billion of contractual obligations due within one year: NIS 599.1 million of bank credit, NIS 182.7 million of commercial paper, NIS 338.4 million of bank loans including current maturities, NIS 97.8 million of bonds including current maturities, plus suppliers, payables and a loan from a subsidiary.

Obviously, not all of that is supposed to be paid tomorrow morning out of cash on hand. But that is precisely the thesis. Vitania's liquidity test sits in access to funding, not in existing excess cash. The company itself describes its policy as allowing maximum flexibility of equity injections into projects until, in its view, a financing bank enters and funds the continuation of the project. That works as long as the bank really does enter, or chooses to remain.

At the project level, the friction is already visible in practice. In La Guardia Phase C there is a total credit framework of NIS 2.2 billion, of which NIS 1.163 billion was utilized, and separately a NIS 300 million line for land and construction costs, of which NIS 168 million was utilized. That is a heavy structure, but still an active one. In Ness Ziona the picture is sharper: a NIS 450 million facility was fully utilized, and after the cancellation of the LDP lease, the bank closed the credit line and the company is now funding the remaining work from its own sources.

That is where the real connection appears between solo liquidity and project funding. As long as a financing bank comes in on time, the company can describe its equity injection as a bridge. The moment a bank pauses or demands changes, that bridge becomes a real cash use at the parent level. That is why the key question for 2026 is not whether Vitania can calculate FFO. It is whether Vitania can lock in extensions, enlarge lines and keep project funding available before the solo cash balance is asked to absorb too much of the burden.

Conclusion

The thesis here is simpler than the headline numbers suggest. Vitania is not being tested on whether it can produce FFO. It is being tested on whether it can roll a large layer of short-dated debt, keep access to banks and debt investors, and move expensive projects into a phase where they fund themselves instead of consuming more corporate cash.

Current thesis in one line: Vitania's real liquidity test runs through bank lines, commercial paper and project funding, not through FFO alone.

What the market could miss is that the projected two-year surplus is not a cushion that already exists. It is the output of an assumption that all the key rollover points will work. If they do, 2026 can look like a controlled bridge year. If one of them weakens, especially in a project that still needs funding through completion, liquidity will tighten well before that shows up in FFO.